Weekly Healthcare Headlines Feature Moderna, Merck, and Twist Bioscience
This week's notable healthcare headlines focus on developments concerning Moderna, Merck, and Twist Bioscience, highlighting key updates in the sector.
19 stories found
This week's notable healthcare headlines focus on developments concerning Moderna, Merck, and Twist Bioscience, highlighting key updates in the sector.
Twist Bioscience announced the pricing of its upsized $300 million equity offering at $96 per share.
Evercore ISI has increased its price target for Twist Bioscience (TWST), indicating a positive outlook for the company's stock.
Twist Bioscience Corporation is being considered a strong buy after Guggenheim raised its price target for the company's stock.
Twist Bioscience Corp's stock price climbed after the company reported earnings that surpassed market expectations.
Powell Industries, Twist Bioscience, and Hess Midstream LP have announced their latest financial results, showing a mix of beats and misses on GAAP EPS and revenue expectations. Twist Bioscience also provided its FY2026 revenue targets and an outlook for adjusted EBITDA breakeven.
Twist Bioscience shares declined after an insider sale exceeding $2 million was reported.

Samsung Electronics stock is surging today, while Twist Bioscience stock has hit a 52-week high at $143.1 USD, reflecting strong market performance for both companies.

Snap's stock surged after the company reported better-than-expected Q2 earnings and revenue, driven by an ad boost from the World Cup, with a strong sales forecast for Q3 and raised 2026 infrastructure cost outlook. Analysts are now evaluating if the company's broadened audience and increased ad revenue are sufficient for sustained growth.
Several company executives have recently sold substantial amounts of their company shares, including MicroStrategy's CEO, Twist Bioscience's Chief Legal Officer, and a director at The Cheesecake Factory.
Twist Bioscience Corp. (TWST) saw its stock rally following the release of a record-breaking quarterly report, indicating strong financial performance.
Highlights from Twist Bioscience's second-quarter earnings call were reported, providing insights into the company's recent financial results and strategic updates.
Twist Bioscience Corp.'s strong revenue growth is further solidifying its position as a leader in technology.
Twist Bioscience (TWST) experienced a surge in its stock value, driven by strong financial results and increasing demand for AI-powered drug discovery.
The CEO of Twist Biosciences (TWST) has reportedly sold 16,000 shares of the company's stock, totaling approximately $1.1 million in value.
Twist Bioscience Corporation (TWST) announced its Q2 2026 financial results, while Cipher Digital (CIFR) released its Q1 2026 financial results. These reports provide updates on the companies' recent fiscal performance.

UniCredit Bank has announced a record quarterly profit, with its net profit in Czechia and Slovakia also seeing a significant increase. This financial performance highlights strong investment income for the banking group.

Apple's stock surged after the company reported strong quarterly earnings, exceeding estimates due to robust iPhone and Mac demand, especially in China, and subsequently boosted its financial guidance.